Arrowhead Publishers is pleased to announce that the 6th Annual Drug Repositioning, Repurposing and Rescue Conference will be taking place June 27-28, 2017 in Chicago, IL. This event will provide a platform for a variety of stakeholders furthering drug development through a variety of collaborations, including patient advocacy efforts and industry/academic/government cooperation. For more information, visit: www.drugrepositioningconference.com/brochure.

This year's conference will be focused on the use of repurposing to find and develop new therapies for rare diseases. Several key themes at this event will include:

  • Patient Advocacy Efforts: Emphasis on and engagement with patient advocacy groups, who are investigating in drug repositioning efforts to an unprecedented degree
  • New Partnerships: The conference will explore how new partnerships between various groups, including government, industry and academia are teaming up to advance repurposing efforts
  • Commercial Case Studies: Leaders in drug repositioning will discuss their successes, failures and the way forward
  • Collaborative efforts: Government/academic/industry collaborations will be explored and highlighted in order to determine how disparate groups can achieve success
  • Systematic Repositioning and Data Analytics: Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success

Featured Speakers Include:

  • Ronald Alfa, MD, Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals
  • Bobbie Ann Austin, Ph.D., Program Officer, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), Office of the Director, National Institutes of Health
  • Pieter Dylst, Senior Manager Market Access and Value Added Medicines, Medicines for Europe
  • Laura Kleiman, Ph.D., Scientific Research Director, cBio Center, Dana-Farber Cancer Institute
  • Daphna Laifenfeld, Ph.D., Sr. Director, Personalized & Predictive Medicine, Teva Pharmaceutical Industries
  • Kevin Pan, Ph.D., Chief Executive Officer, Asieris Pharmaceuticals
  • Aris Persidis, Ph.D., President, Biovista
  • Michael Pollastri, Ph.D., Associate Professor & Chair, Northeastern University, College of Science
  • Vidula Sukhatme, Founder and CEO, Global Cures

Please visit www.drugrepositioningconference.com/speakers for the full speaking faculty.

For more information, please contact:

John Waslif: Managing Director, Arrowhead Publishers
866-945-0263 ext 700, john.waslif@arrowheadpublishers.com

Rachel Donlon: Marketing Associate, Arrowhead Publishers
866-945-0263 ext 701, rachel.donlon@arrowheadpublishers.com